BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28425048)

  • 21. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
    Anzalone N; Castellano A; Cadioli M; Conte GM; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Grillea G; Vitali P; Aquino D; Terreni MR; Torri V; Erickson BJ; Caulo M
    Radiology; 2018 Jun; 287(3):933-943. PubMed ID: 29361245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
    Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
    Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
    [No Abstract]   [Full Text] [Related]  

  • 23. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
    Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
    Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
    Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Boxerman JL; Ellingson BM; Jeyapalan S; Elinzano H; Harris RJ; Rogg JM; Pope WB; Safran H
    Am J Clin Oncol; 2017 Jun; 40(3):228-234. PubMed ID: 25436828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating feasibility of high resolution T1-perfusion MRI with whole brain coverage using compressed SENSE: Application to glioma grading.
    Sasi S D; Ramaniharan AK; Bhattacharjee R; Gupta RK; Saha I; Van Cauteren M; Shah T; Gopalakrishnan K; Gupta A; Singh A
    Eur J Radiol; 2020 Aug; 129():109049. PubMed ID: 32464580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioma grade discrimination with dynamic contrast-enhanced MRI: An accurate analysis based on MRI guided stereotactic biopsy.
    Wu J; Liang Z; Deng X; Xi Y; Feng X; Yao Z; Shu Z; Xie Q
    Magn Reson Imaging; 2023 Jun; 99():91-97. PubMed ID: 36803634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative MRI for analysis of peritumoral edema in malignant gliomas.
    Blystad I; Warntjes JBM; Smedby Ö; Lundberg P; Larsson EM; Tisell A
    PLoS One; 2017; 12(5):e0177135. PubMed ID: 28542553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An MRS- and PET-guided biopsy tool for intraoperative neuronavigational systems.
    Grech-Sollars M; Vaqas B; Thompson G; Barwick T; Honeyfield L; O'Neill K; Waldman AD
    J Neurosurg; 2017 Oct; 127(4):812-818. PubMed ID: 27834593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
    Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
    Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?
    Little RA; Barjat H; Hare JI; Jenner M; Watson Y; Cheung S; Holliday K; Zhang W; O'Connor JPB; Barry ST; Puri S; Parker GJM; Waterton JC
    Magn Reson Imaging; 2018 Feb; 46():98-105. PubMed ID: 29154898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.
    Larsson C; Kleppestø M; Rasmussen I; Salo R; Vardal J; Brandal P; Bjørnerud A
    J Magn Reson Imaging; 2013 Apr; 37(4):818-29. PubMed ID: 23086710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New similarity search based glioma grading.
    Haegler K; Wiesmann M; Böhm C; Freiherr J; Schnell O; Brückmann H; Tonn JC; Linn J
    Neuroradiology; 2012 Aug; 54(8):829-37. PubMed ID: 22160184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.
    Rochetams BB; Marechal B; Cottier JP; Gaillot K; Sembely-Taveau C; Sirinelli D; Morel B
    Neuroradiol J; 2017 Oct; 30(5):429-436. PubMed ID: 28556691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of B
    Sengupta A; Gupta RK; Singh A
    J Transl Med; 2017 Dec; 15(1):242. PubMed ID: 29197390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misleading FLAIR imaging pattern after glioma surgery with intraoperative MRI.
    Lescher S; Jurcoane A; Schniewindt S; Senft C; Hattingen E
    Neurosurg Rev; 2016 Jan; 39(1):79-85; disucssion 85-6. PubMed ID: 26201972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
    Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
    Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of histogram analysis for the evaluation of vascular permeability in glioma by the K2 parameter obtained with the dynamic susceptibility contrast method: Comparisons with Ktrans obtained with the dynamic contrast enhance method and cerebral blood volume.
    Taoka T; Kawai H; Nakane T; Hori S; Ochi T; Miyasaka T; Sakamoto M; Kichikawa K; Naganawa S
    Magn Reson Imaging; 2016 Sep; 34(7):896-901. PubMed ID: 27109485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.